1 year return (CAGR)
1601.93%
Terns Pharmaceuticals Inc Exchange (NASDAQ, USD)
TERN
52.93
+0.01 (+0.02%)
HealthcareBiotechnology
Loading...
3 year return (CAGR)
61.65%
5 year return (CAGR)
22.83%
10 year return (CAGR)
-
Objective Corporation Stock Analysis – State Within State
Read MoreMarketcap
6.11B
Price/Sales
-
Ent value
5.61B
Price/Book
-
Div yield
0.00%
Growth years
-
Div growth
-
FCF payout
0.00%
Trailing P/E
-
PEG
-
Forward P/E
-
EPS growth
-
Stock information
What is a stock exchange? Operation, actors, examples
Read MoreStock chart
Loading...
Stock price data
| Open | 52.95 |
| Daily high | 52.95 |
| Daily low | 52.92 |
| Daily Volume | 1.77M |
| All-time high | 53.17 |
| 1y analyst estimate | 53.00 |
| Beta | -0.38 |
| EPS (TTM) | - |
| Dividend per share | 0.00 |
| Ex-div date | - |
| Next earnings date | 31 Mar 2026 |
Downside potential
Loading...
Downside potential data
| TERN | S&P500 | |
| Current price drop from All-time high | -0.45% | -0.49% |
| Highest price drop | -94.50% | -56.47% |
| Date of highest drop | 20 May 2022 | 9 Mar 2009 |
| Avg drop from high | -66.34% | -10.68% |
| Avg time to new high | 53 days | 12 days |
| Max time to new high | 1173 days | 1805 days |
News
No items found